Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.
Labrecque MP, Coleman IM, Brown LG, True LD, Kollath L, Lakely B, Nguyen HM, Yang YC, da Costa RMG, Kaipainen A, Coleman R, Higano CS, Yu EY, Cheng HH, Mostaghel EA, Montgomery B, Schweizer MT, Hsieh AC, Lin DW, Corey E, Nelson PS, Morrissey C.
Labrecque MP, et al. Among authors: montgomery b.
J Clin Invest. 2019 Jul 30;129(10):4492-4505. doi: 10.1172/JCI128212.
J Clin Invest. 2019.
PMID: 31361600
Free PMC article.